MC
CVS icon

Moors & Cabot’s CVS Health CVS Stock Holding History

Moors & Cabot’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$2K – 633
2019
Q3 		$2K Buy
+1,000
New +$59.3K ﹤0.01% 662

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Moors & Cabot's CVS Position: Q1 2026 in Review

Moors & Cabot reduced its CVS Health (CVS) stake by 47% in Q1 2026, selling an estimated $3.59M and leaving 52,346 shares worth $3.76M. The position accounts for 0.16% of the portfolio, ranked #134.

Moors & Cabot first reported a position in CVS in Q1 2014 and has held it in 49 quarters since. The position peaked at $22.9M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Moors & Cabot held 52,346 shares of CVS Health worth $3.76M as of Q1 2026.
  • Moors & Cabot sold 46,567 CVS Health shares in Q1 2026, an estimated $3.59M.
  • CVS Health made up 0.16% of Moors & Cabot's portfolio in Q1 2026, its #134 holding.
  • Moors & Cabot first reported a position in CVS Health in Q1 2014 and has held it in 49 quarters since.
  • Moors & Cabot's CVS Health position peaked at $22.9M in Q4 2021.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.